BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10609878)

  • 1. Thioctic acid--effects on insulin sensitivity and glucose-metabolism.
    Jacob S; Rett K; Henriksen EJ; Häring HU
    Biofactors; 1999; 10(2-3):169-74. PubMed ID: 10609878
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes.
    Evans JL; Goldfine ID
    Diabetes Technol Ther; 2000; 2(3):401-13. PubMed ID: 11467343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid.
    Jacob S; Henriksen EJ; Tritschler HJ; Augustin HJ; Dietze GJ
    Exp Clin Endocrinol Diabetes; 1996; 104(3):284-8. PubMed ID: 8817248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin sensitizer drugs--review].
    Yamanouchi T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Natural Compounds and Their Derivatives as a Source of Promising Drugs for Diabetes and Insulin Resistance.
    Mena Barreto Silva FR; Silva Frederico MJ
    Curr Drug Targets; 2017; 18(6):618. PubMed ID: 28831919
    [No Abstract]   [Full Text] [Related]  

  • 6. Two herbal preparations, Cordyceps Cs4 and Cogent db: do they act on blood glucose, insulin sensitivity, and diabetes as "viscous dietary fibers?".
    Hockaday TD
    J Altern Complement Med; 2002 Aug; 8(4):403-5. PubMed ID: 12230899
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study.
    Karlsson HK; Hällsten K; Björnholm M; Tsuchida H; Chibalin AV; Virtanen KA; Heinonen OJ; Lönnqvist F; Nuutila P; Zierath JR
    Diabetes; 2005 May; 54(5):1459-67. PubMed ID: 15855334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in glucokinase activators for the treatment of type 2 diabetes.
    Pal M
    Drug Discov Today; 2009 Aug; 14(15-16):784-92. PubMed ID: 19520181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise intensity and insulin sensitivity: how low can you go?
    Hawley JA; Gibala MJ
    Diabetologia; 2009 Sep; 52(9):1709-13. PubMed ID: 19557385
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
    Schatz H
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
    [No Abstract]   [Full Text] [Related]  

  • 11. The direct and indirect effects of insulin on hepatic glucose production in vivo.
    Cherrington AD; Edgerton D; Sindelar DK
    Diabetologia; 1998 Sep; 41(9):987-96. PubMed ID: 9754815
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes.
    Ferrannini E
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):25-39. PubMed ID: 22575405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From insulin secretion to insulin therapy].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1240-6. PubMed ID: 9767787
    [No Abstract]   [Full Text] [Related]  

  • 14. [New therapeutic approaches in type II diabetes].
    Reach G
    Journ Annu Diabetol Hotel Dieu; 1993; ():155-60. PubMed ID: 8331862
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulation of cardiac glucose transport by thioctic acid and insulin.
    Ramrath S; Tritschler HJ; Eckel J
    Horm Metab Res; 1999 Dec; 31(12):632-5. PubMed ID: 10668913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.
    Wiernsperger NF; Bailey CJ
    Drugs; 1999; 58 Suppl 1():31-9; discussion 75-82. PubMed ID: 10576523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
    Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
    [No Abstract]   [Full Text] [Related]  

  • 18. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
    Freund P; Wolff HP; Kühnle HF
    Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin secretion is increased depending on glucose.. Metabolism regulation in type 2 diabetes mellitus over five paths].
    MMW Fortschr Med; 2009 May; 151(19):50. PubMed ID: 19827447
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of rapid insulin secretion: revisited.
    Grodsky GM
    Diabetes Technol Ther; 1999; 1(3):259-60. PubMed ID: 11475271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.